Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control

Maoying Li, Xi Wang, Jiehui Chen, Tao Deng, Cuihong Lian

Open source

DOI
10.2147/ccid.s584941
Published
2026-03
Container
Clinical, Cosmetic and Investigational Dermatology
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ccid.s584941,
  title = {Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control},
  author = {Maoying Li and Xi Wang and Jiehui Chen and Tao Deng and Cuihong Lian},
  year = {2026},
  journal = {Clinical, Cosmetic and Investigational Dermatology},
  doi = {10.2147/ccid.s584941},
  url = {https://doi.org/10.2147/ccid.s584941}
}

RIS

TY  - JOUR
TI  - Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
AU  - Maoying Li
AU  - Xi Wang
AU  - Jiehui Chen
AU  - Tao Deng
AU  - Cuihong Lian
PY  - 2026
JO  - Clinical, Cosmetic and Investigational Dermatology
DO  - 10.2147/ccid.s584941
UR  - https://doi.org/10.2147/ccid.s584941
ER  - 

APA

Li, M., Wang, X., Chen, J., Deng, T., & Lian, C. (2026). Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control. Clinical, Cosmetic and Investigational Dermatology. https://doi.org/10.2147/ccid.s584941

Source records